Assessment of Migration of the Urethral Bulking Agent Zhoabex G® from the Urethral Injection Site to the Distant Organs in a Rabbit Model
Open Access
- 22 October 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10286
Abstract
Hyaluronic acid (HA)-based urethral bulking agents are promising for the treatment of stress urinary incontinence (SUI), but migration risks to distant organs remain a concern. This study evaluated the migration and cytotoxicity of Zhoabex G®, an HA-based bulking agent, in a female rabbit model. Twenty-seven female New Zealand white rabbits were randomized into control (no injection), sham (saline), and experimental (Zhoabex G®) groups (n = 9 each). After 5 months, tissues from the kidney, lung, liver, and spleen were analyzed using quantitative RT-PCR for hyaluronan synthase (HAS1, HAS2, HAS3) and hyaluronidase (HYAL2) gene expression, and ELISA for HA concentrations. No significant differences in gene expression were observed across groups (p ≥ 0.05, range: 0.166–0.997), with experimental fold change values near sham baselines (e.g., kidney HAS2: 0.987 ± 0.071, p = 0.422). Similarly, HA concentrations showed no group differences (p = 0.577; e.g., kidney: 119.2–121.8 ng/mL), reflecting organ-specific basal levels. These findings indicate that Zhoabex G® remains localized at the urethral injection site, with no evidence of migration or cytotoxicity in distant organs. The biodegradable and non-particulate nature of Zhoabex G® further supports its safety for SUI treatment, warranting further clinical investigation.Keywords
Funding Information
- CMHS, AGU (G1-AGU-4-23)
This publication has 24 references indexed in Scilit:
- Microarchitectural changes in the urethral wall after injecting hyaluronic acid based bulking agent (Zhoabex G): an experimental study in New Zealand white female rabbitsTranslational Research in Anatomy, 2025
- Update on Urethral Bulking for Stress Urinary Incontinence in WomenCurrent Urology Reports, 2022
- Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic reviewNeurourology and Urodynamics, 2021
- Urethral bulking agents for female stress urinary incontinenceNeurourology and Urodynamics, 2019
- Urethral injection therapy for urinary incontinence in womenCochrane Database of Systematic Reviews, 2017
- Randomized Controlled Multisite Trial of Injected Bulking Agents for Women With Intrinsic Sphincter Deficiency: Mid-urethral Injection of Zuidex Via the Implacer Versus Proximal Urethral Injection of Contigen CystoscopicallyUrology, 2009
- Hyaluronan in skin: aspects of aging and its pharmacologic modulationClinics in Dermatology, 2008
- Measurement of high-molecular-weight hyaluronan in solid tissue using agarose gel electrophoresisAnalytical Biochemistry, 2002
- Particulate Silicone for Use in Periurethral Injections: Local Tissue Effects and Search for MigrationJournal of Urology, 1995
- Migration and Granulomatous Reaction After Periurethral Injection of Polytef (Teflon)JAMA, 1984